α-Methylacyl CoA racemase (P504S): Overview and potential uses in diagnostic pathology as applied to prostate needle biopsies

Journal of Clinical Pathology

Volumn 56, Issue 12, 2003, Pages 892-897

  Evans, A J ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ANTIBODY; BIOLOGICAL MARKER; EOSIN; HEMATOXYLIN; PROTEIN 34BETAE12; PROTEIN P63; RACEMASE; UNCLASSIFIED DRUG;

BASAL CELL; CANCER CYTODIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; PROTEIN EXPRESSION; REVIEW; STAINING; STANDARD; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0348041938     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.12.892     Document Type: Review

References (29)

1. Thorson P, Humphrey PA. Minimal adenocarcinoma in prostate needle biopsy tissue. Am J Clin Pathol 2000;114:896-909.
2. Abrahams N, Ormsby A, Brainard J. Cytokeratin 5/6 is a basal cell-specific marker in benign prostatic glandular proliferations and in prostate tissue with androgen deprivation effect. Mod Pathol 2002;15:150A.
3. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002;15:1302-8.
4. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol 1999;12:472-8.
5. Oliai BR, Kahane H, Epstein JI. High molecular weight cytokeratin (HMWCK) reactivity in prostate carcinoma. Mod Pathol 2002;15:176A.
6. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000;60:1677-82.
7. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
8. Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287:1662-70.
9. Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62:2220-6.
10. Schmitz W, Albers C, Fingerhut R, et al. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem 1995;231:815-22.
11. Van Veldhoven PP, Croes K, Casteels M, et al. 2-methylacyl racemase: a coupled assay based on the use of pristanoyl-CoA oxidase/peroxidase and reinvestigation of its subcellular distribution in rat and human liver. Biochim Biophys Acta 1997;1347:62-8.
12. Ferdinandusse S, Denis S, IJlst L, et al. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 2000;41:1890-6.
13. Ferdinandusse S, Denis S, Clayton PT, et al. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 2000;24:188-91.
14. Zheng SL, Chang BL, Faith DA, et al. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 2002;62:6485-8.
15. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001;23:87-92.
16. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 2001;23:72-81.
17. Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002;26:926-31.
18. Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002;26:1169-74.
19. Beach R, Gown AM, Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002;26:1588-96.
20. Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 2002;26:921-5.
21. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25:1397-404.
22. Kuefer R, Varambally S, Zhou M, et al. Alpha-methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 2002;161:841-8.
23. Iczkowski KA, Jiang Z, Tretiakova M, et al. Prostatic needle biopsies with suspicious (ASAP) diagnosis: 80% resolved using P504S/AMACR and keratin 34bE12 immunostaining. Mod Pathol 2003;16:154A.
24. Kunju LP, Rubin MA, Shen R, et al. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha-methylacyl-CoA racemase in benign atypical and malignant prostate tissues. Mod Pathol 2003;16:158A.
25. Jiang Z, Tretiakova M, Steinberg G, et al. Overexpression of alpha-methylacyl-CoA racemase/P504S in recurrent prostatic adenocarcinoma after radiation. Mod Pathol 2003;16:155A.
26. Amin M, Beach R, Gown AM, et al. Use of a novel immunohistochemical (IHC) panel (P504S, p63 and 34BE12) in the diagnosis of post-radiation therapy (PRT) prostate cancer (PCa). Mod Pathol 2003;16:139A.
27. Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol 2003;27:365-71.
28. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822-6.
29. Harik L, Cui LY, Sen B, et al. Immunohistochemical analysis of a novel prostate epithelial cell-specific gene "PrLZ" protein in prostatic epithelia in radical prostatectomy specimens. Mod Pathol 2003;16:153A.